The project is born out of a concrete demand within the pharma supply chain to provide a hi-tech solution to tackle the problem of limited-supply and out-of-stock medicine.
AI is becoming an integral part of our society. This article presents how it can be applied, whether in the B2C or the B2B context, and the relationship between AI, Machine Learning and Deep Learning.
The European Union must also contend with a constantly evolving market and socio-economic fabric, revising its objectives and directives in light of these transformations.